clinical trial | Cannabis Daily Record

WIRE: Study shows oral THC safe and effective treatment for symptoms of anorexia

May 24, 2018 // 0 Comments

Jerusalem, Israel: The daily administration of low doses of oral THC is associated with treating various symptoms associated with anorexia nervosa, according to clinical [...]

WIRE: Study indicates CBD is effective as adjunctive therapy for psychosis

December 26, 2017 // 0 Comments

London, United Kingdom — The daily administration of CBD (cannabidiol) as an adjunctive therapy mitigates psychotic symptoms in patients with schizophrenia, [...]

WIRE: Israeli study finds gelatin CBD capsules are safe and effective

December 11, 2017 // 0 Comments

Tel Aviv, Israel — The oral administration of gelatin capsules containing purified cannabidiol (CBD) is safe and efficient in human subjects, according to clinical [...]

WIRE: Literature survey shows cannabis effective for pain, epilepsy and MS

November 27, 2017 // 0 Comments

Boston, MA: Substantial clinical trial data exists to support the efficacy of medical cannabis in the treatment of chronic pain conditions, pediatric epilepsy, and multiple [...]

WIRE: Oral THC mitigates sleep apnea in new study

November 20, 2017 // 0 Comments

Chicago, IL — The use of oral THC mitigates sleep apnea symptoms compared to placebo, according to clinical trial data published online ahead of print in the [...]

WIRE: CBD administration reduces blood pressure in new study

June 30, 2017 // 0 Comments

Oxford, United Kingdom — Oral CBD administration is associated with reduced blood pressure in healthy volunteers, according to clinical trial data published online in [...]

WIRE: Study shows cannabis extract associated with reduced ADHD symptoms

June 19, 2017 // 0 Comments

London, United Kingdom — The administration of whole-plant cannabis extracts is associated with improvements in cognition and behavior in subjects with Attention [...]

WIRE: Canadian company prepares phase III trial for smoked cannabis cancer pain treatment

June 9, 2017 // 0 Comments

OTTAWA, ONTARIO – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(OTCQB: TBPMF), and PhytoPain Pharma (PPP), a subsidiary of Tetra [...]

WIRE: In new study, CBD reduces seizures in severe epilepsy disorder

May 31, 2017 // 0 Comments

NEW YORK — After years of anecdotal claims about its benefits, the cannabis derivative cannabidiol reduced seizure frequency by 39 percent for patients with Dravet [...]

WIRE: Study indicates cannabis extract can improve brain tumor survival rates

February 14, 2017 // 0 Comments

London, United Kingdom — Brain tumor patients treated with cannabis extracts possessed increased one-year survival rates compared to those who went untreated, [...]